CLESHEREE STEPTER: Open Payments
NPI 1871866830 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,160 in 128 payments from 39 companies in 2025. Trend: 2023 $2,022 · 2024 $2,100 · 2025 $3,160
Food & beverage: $2,872Education: $288
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $274 |
| Celgene Corporation | 11 | $263 |
| Janssen Biotech, Inc. | 10 | $215 |
| Legend Biotech USA Inc. | 5 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $190 |
| Daiichi Sankyo Inc. | 7 | $160 |
| E.R. Squibb & Sons, L.L.C. | 2 | $146 |
| ABBVIE INC. | 5 | $122 |
| Incyte Corporation | 6 | $120 |
| PFIZER INC. | 6 | $105 |
Products named: BREYANZI, CARVYKTI, Vanflyta, Vyloy, ELREXFIO, Epkinly, BRUKINSA, NINLARO.
Industry payments across TN — which companies pay providers there.
